The frequency of clonally expanded and persistent T cells recognizing the immunodominant autoantigenic peptide of myelin basic protein (MBP)p85-99 was directly measured ex vivo in subjects with typical relapsing remitting multiple sclerosis (MS). T cells expressing mRNA transcripts encoding T cell receptor (TCR)-α and -β chains found in T cell clones previously isolated from these subjects recognizing the MBPp85-99 epitope were examined. In contrast to frequencies of 1 in 105–106 as measured by limiting dilution analysis, estimates of the T cell frequencies expressing MBPp85-99–associated TCR chain transcripts were as high as 1 in 300. These high frequencies were confirmed by performing PCR on single T cells isolated by flow cytometry. MBPp85-99 TCR transcripts were present in IL-2 receptor α–positive T cells which were induced to undergo Fas-mediated cell death upon antigen stimulation. These data demonstrate that at least a subpopulation of patients with MS can have a very high frequency of activated autoreactive T cells.
Direct Ex Vivo Analysis of Activated, Fas-sensitive Autoreactive T Cells in Human Autoimmune Disease
Address correspondence to Dr. David A. Hafler, Laboratory of Molecular Immunology, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Ave., Boston, MA 02115.
1 Abbreviations used in this paper: CDR3, third-complementarity-determining region; CNS, central nervous system; dd, double distilled; dNTP, deoxynucleotide triphosphate; dT, deoxythimidine; IL-2Rα, IL-2 receptor α; LB, luria broth; LDA, limiting dilution analysis; MBP, myelin basic protein; MS, multiple sclerosis; PLP, proteolipid protein; WMNC, whole mononuclear cells.
Katarzyna D. Bieganowska, Lara J. Ausubel, Yalda Modabber, Elissa Slovik, Wells Messersmith, David A. Hafler; Direct Ex Vivo Analysis of Activated, Fas-sensitive Autoreactive T Cells in Human Autoimmune Disease. J Exp Med 5 May 1997; 185 (9): 1585–1594. doi: https://doi.org/10.1084/jem.185.9.1585
Download citation file:
Sign in
Client Account
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement